SCHEMBL21695014

SCHEMBL21695014

CCCC(OC(=O)CC(C)=O)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
FAAH O00519 5/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
TRPV1 Q8NER1 1/20 0.33
LMNA P02545 2/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
CTSK P43235 3/20 0.32
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757907 0.82 LMNA (0.44) FAAHCNR1CNR2LMNACHRM1
SCHEMBL29190726 0.80 FAAH (0.49) MGAMGAASIMGAM2FAAH
SCHEMBL21766837 0.80 MGAM (0.44) MGAMGAASIMGAM2TRPV1
SCHEMBL17882020 0.80 ALDH1A1 (0.44) FAAHCNR1CNR2LMNAHDAC8
SCHEMBL28084580 0.79 TRPV1 (0.44) FAAHTRPV1LMNAHDAC7HDAC8
SCHEMBL2381597 0.78 MGAM (0.46) MGAMGAASIMGAM2FAAH
SCHEMBL14991338 0.77 CHRM1 (0.37) FAAHCNR1CNR2TRPV1LMNA
SCHEMBL17878555 0.77 LMNA (0.40) LMNACHRM1AKR1A1CHRM3HTR2A
SCHEMBL31647151 0.76 MGAM (0.34) MGAMGAASIMGAM2LMNA
SCHEMBL9681647 0.76 MGAM (0.44) MGAMGAASIMGAM2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11649334-B2 Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate ADEKA CORPORATION (JP) 2023-05-16 US disclosed
US-20200032021-A1 WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE ADEKA CORPORATION (JP) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200032021-A1 WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE PHOSPHO1, ASS1, SGMS1 MGAM 3070/4885GAA 1501/4885SI 2283/4885
US-11649334-B2 Water-soluble composition, production method for cured product thereof, and cured product thereof, and acyl phosphinate PHOSPHO1, ASS1, SGMS1 MGAM 3070/4885GAA 1501/4885SI 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.